Amco India (530133)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹60.46 |
| Market Cap | ₹25.48 Cr |
| P/E Ratio | 48.73 |
| ROCE | 7.64% |
| ROE | 1.71% |
| Dividend Yield | 0% |
| Profit Growth | -77.27% |
| Debt/Equity | — |
| Sales Growth | -0.04% |
| 52-Week Range | ₹60.16 — ₹104.99 |
| Sector | Industrial Products |
| Book Value | ₹91.88 |
Strengths
- Trades at a 34% discount to book value (₹60.46 vs ₹91.88 per share)
- ROCE of 7.64% is positive, showing some operating cash-generating ability
- Sales are nearly stable at -0.04%, so the topline is not collapsing
- Market cap of ₹25 Cr keeps the stock close to its 52-week low, limiting speculative froth
Concerns
- Profit growth has plunged 77.27%, and the latest quarter reported zero net profit on ₹29 Cr sales
- ROE of 1.71% is far below any reasonable cost of equity, indicating value erosion
- Piotroski F-Score of 3/9 reflects weak financial health across profitability, leverage, and efficiency
- P/E of 48.73 is expensive despite collapsing earnings, with no dividend to compensate shareholders
AI Analysis
When I look at Amco India, I see a business that trades like a bargain but earns like a laggard. The share sits at ₹60.46, against a book value of ₹91.88 – a 34% discount. That is enough to catch any Graham-style investor’s attention. But a low P/B is only meaningful if the assets can earn a fair return. Here, ROE is a paltry 1.71%, and ROCE is just 7.64%. The latest quarter shows sales of ₹29 Cr but net profit of exactly ₹0 Cr. Profit growth has collapsed by 77.27%, while sales growth is essentially flat at -0.04%. This is a commodity-margin business in aluminium, copper and zinc products – not a franchise with pricing power. The P/E of 48.73 is ridiculous when earnings are vanishing, and the Piotroski F-Score of 3/9 points to poor financial health. The company pays no dividend, so patient shareholders get no income while waiting. I cannot even check promoter holding or debt levels, as that data isn’t available, which adds uncertainty. Still, there is an asset angle: the stock is close to its 52-week low of ₹60.16, and the book value offers a cushion if liquidation value holds. But remember, book value can shrink if losses continue. I’d call this a potential asset play, not a quality compounder. I need to see consistent quarterly profits and a return on equity above the cost of capital before I treat it as a serious investment. Until then, this is a classic value trap – cheap for a reason.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer